[关于五种单克隆抗体、兔多克隆抗体及人F VIII/vWF同源抗体对瑞斯托菌素诱导的血小板凝集及玻璃珠柱血小板滞留作用的研究] - Suppr | 超能文献

[Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].

作者信息

Ogata K, Minami S, Kamiya T

出版信息

Rinsho Ketsueki. 1985 Jul;26(7):1042-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].[关于五种单克隆抗体、兔多克隆抗体及人F VIII/vWF同源抗体对瑞斯托菌素诱导的血小板凝集及玻璃珠柱血小板滞留作用的研究]

Rinsho Ketsueki. 1985 Jul;26(7):1042-9.

2

Characterisation of a monoclonal antibody to von Willebrand factor as a potent inhibitor of ristocetin-mediated platelet interaction and platelet adhesion.一种针对血管性血友病因子的单克隆抗体作为瑞斯托霉素介导的血小板相互作用和血小板黏附的强效抑制剂的特性研究。

Thromb Haemost. 1987 Jun 3;57(3):278-82.

3

The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.一种单克隆抗体所证实的，支持瑞斯托霉素诱导的血小板凝集的抗血友病因子（因子VIII）特性（因子VIIIR:RC）与玻璃珠对血小板的滞留之间的关系。

Blood. 1983 Jan;61(1):27-35.

4

Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies.单克隆抗体对因子VIII-血管性血友病因子瑞斯托霉素辅因子活性的增强作用。

Thromb Haemost. 1985 Aug 30;54(2):510-4.

5

Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.针对凝血因子VIII-血管性血友病因子的25种单克隆抗体的特性：瑞斯托霉素诱导的血小板聚集与血小板黏附于内皮下之间的关系

Blood. 1984 Jun;63(6):1408-15.

6

Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.血管性血友病中因子VIII（活性与抗原）及瑞斯托霉素诱导的血小板聚集之间的解离

Acta Haematol. 1975;53(1):44-8. doi: 10.1159/000208154.

7

Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.抗人血管性血友病因子单克隆抗体AJvW-2的抗血栓形成作用及出血风险

Br J Pharmacol. 1997 Sep;122(1):165-71. doi: 10.1038/sj.bjp.0701354.

8

Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.对3型血管性血友病患者体内产生的两种同种抗体的图谱绘制及功能研究。

Thromb Haemost. 2000 Feb;83(2):274-81.

9

A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.一种针对血管性血友病因子活性亚群的人骨髓瘤产生的单克隆蛋白。

Am J Clin Pathol. 1986 Jan;85(1):115-23. doi: 10.1093/ajcp/85.1.115.

10

Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.对血管性血友病中缺乏的、血小板聚集所必需的一种血浆因子进行定量测定。与凝血因子VIII促凝活性及抗原含量的关系。

J Clin Invest. 1973 Nov;52(11):2708-16. doi: 10.1172/JCI107465.